ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
University of Calgary at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
University of Calgary brings 11 presentations to ACR Convergence 2026 in Orlando. Its program centres on lupus biomarkers, from urinary complement products to autoantibody testing and the cost of organ damage, and on myositis therapy. It also covers menopausal hormone therapy and cellular immunotherapy.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
University of Calgary Calgary, Canada | |
A public research university in Calgary, Alberta. | Session Sun Nov 8 10:00am–11:30am Precision Over Prednisone: Mechanism-Based Therapy for Dermatomyositis in the Modern Era
Poster Sun Nov 8 10:30am–12:30pm Session Sun Nov 8 3:00pm–4:00pm Menopausal Hormone Therapy in 2026: What Rheumatologists Need to Know
Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Session Mon Nov 9 1:00pm–2:30pm Abstracts: Epidemiology & Public Health I (1886-1891)
Session Mon Nov 9 4:00pm–5:00pm Bench to Bedside: Updates on Lupus Biomarkers
Talk Mon Nov 9 4:00pm–4:20pm Updates on ANA and Autoantibodies Poster Tue Nov 10 10:30am–12:30pm Session Tue Nov 10 1:00pm–2:30pm Cellular Immunotherapy: Are we on the Cusp of a Therapeutic Revolution in Rheumatology? Session 3
|
Find decision makers at University of Calgary
Tell us what you sell and we’ll find the people at University of Calgary most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction